Hinokitiol, a natural tropolone derivative attenuates inflammoalgesia induced by LPS in experimental animals

Year 2024, Volume: 28 Issue: 6 , 1989 - 2000 , 28.06.2025

Shivshankar Gunjegoankar Aparna Bhaleroa Amol Joshi Kishor Dherange Samarth Pimparkar Amruta Sawant

https://doi.org/10.29228/jrp.873

Cited By: 1

https://izlik.org/JA78XK73XR

Abstract

Hinokitiol is a natural bioactive compound synthesized as a secondary metabolite in numerous aromatic, medicinal plants and commonly used in food and cosmetic industries. The investigation was carried out to screen the potential activity of hinokitiol against LPS-induced inflammation, algesia, and oxidative stress in experimental animals. The hinokitiol was screened in two doses, i.e. 0.2 mg/kg (H-1), 0.4 mg/kg (H-2), and inflammoalgesia were induced by intraplantar administration of lipopolysaccharides (LPS) at a dose of 1 mg/kg. The assessment was carried out on the 7th, 14th, 21st, and 28th days for the severity of arthritic hyperalgesia score, secondary inflammatory lesions, stair climbing ability, motility, and dorsal flexion-pain score test. Serum analysis was carried out for tumor necrosis factor-alpha (TNF α), interleukin (IL-2 and IL-6), prostaglandin (PGE-2), nitric oxide (NO), and thymus/spleen index. The joint samples were further subjected to histopathological observations. The results showed that treatment with H-1 and H-2 shows dose-dependent significant decreases (P<0.05) in arthritic hyperalgesia and secondary lesions, whereas a significant increase (P<0.05) in stair climbing ability, motility, and dorsal flexion pain score test was noted. Treatment with H-1 and H-2 shows significant lowering (P<0.05) in serum TNF-α, IL-2, IL-6, PGE-2, NO, and thymus/spleen index. Histopathological observations indicated minimal damage and restored the synovial structure. The present study reveals that hinokitiol shows significant anti-inflammatory, anti-algesic, and antioxidant effects against LPS-induced inflammation in experimental animals.

Keywords

Hinokitiol , Lipopolysaccharide , Arthritis , Inflammation , Hyperalgesia , Inflammatory mediators

References

• [1] Cao P, Li Y, Tang Y, Ding C. Hunter, D. J. Pharmacotherapy for knee osteoarthritis: Current and emerging therapies. Expert Opin Pharmacother. 2020; 21(7): 797-809. https://doi.org/10.1080/14656566.2020.1732924
• [2] Weaver P, Brual R, Blair D. Analgesia and sedation in critically Ill patients with burns. AACN Adv Crit Care. 2022; 33(2): 125-129. https://doi.org/10.4037/aacnacc2022588
• [3] Reeh PW, Fischer MJM. Nobel somatosensations and pain. Pflugers Arch. 2022;474(4):405-420.. Erratum in: Pflugers Arch. 2022 Jun;474(6):647. https://doi.org/10.1007/s00424-022-02667-x
• [4] Cobo MM, Green G, Andritsou F, Baxter L, Evans Fry R, Grabbe A, Gursul D, Hoskin A, Mellado GS, van der Vaart M, Adams E, Bhatt A, Denk F, Hartley C, Slater R. Early life inflammation is associated with spinal cord excitability and nociceptive sensitivity in human infants. Nat Commun. 2022;13(1):3943. https://doi.org/10.1038/s41467-022 31505-y
• [5] DomperArnal MJ, Hijos-Mallada G, Lanas A. Gastrointestinal and cardiovascular adverse events associated with NSAIDs. Expert Opin Drug Saf. 2022; 21(3): 373-384. https://doi.org/10.1080/14740338.2021.1965988
• [6] Zhang P, Li K, Kamali A, Ziadlou R, Ahmad P, Wang X, Richards RG, Alini M, Basoli V, Li Z, Grad S. Small molecules of herbal origin for osteoarthritis treatment: in vitro and in vivo evidence. Arthritis Res Ther. 2022;24(1):105. https://doi.org/10.1186/s13075-022-02785-y
• [7] Huang CH, Jayakumar T, Chang CC, Fong TH, Lu SH, Thomas PA, Choy CS, Sheu JR. Hinokitiol exerts anticancer activity through downregulation of MMPs 9/2 and enhancement of catalase and SOD enzymes: In vivo augmentation of lung https://doi.org/10.3390/molecules201017720 histoarchitecture. Molecules. 2015;20(10):17720-17734.
• [8] Xu Y, Wang S, Miao Q, Jin K, Lou L, Ye X, Xi Y, Ye J. Protective role of hinokitiol against H2O2-induced injury in human corneal epithelium. Curr Eye Res. 2017; 42(1): 47-53. https://doi.org/10.3109/02713683.2016.1151530
• [9] Chelpuri Y, Pabbathi S, Alla GR, Yadala RK, Kamishetti M, Banothu AK, Boinepally R, Bharani KK, Khurana A. Tropolone derivative hinokitiol ameliorates cerulein-induced acute pancreatitis in mice. Int Immunopharmacol. 2022; 109: 108915. https://doi.org/10.1016/j.intimp.2022.108915
• [10] El Hachlafi N, Lakhdar F, Khouchlaa A, Bakrim S, El Omari N, Balahbib A. Health benefits and pharmacological properties of hinokitiol. Processes. 2021; 9(9): 1680. https://doi.org/10.3390/pr9091680 [11] Krenn BM, Gaudernak E, Holzer B, Lanke K, Van Kuppeveld FJ, Seipelt J. Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections. J Virol. 2009; 83(1):58-64. https://doi.org/10.1128/JVI.01543-08
• [12] Wang Y, Liu X, Chen T, Xu Y, Tian S. Antifungal effects of hinokitiol on development of Botrytis cinerea in vitro and in vivo. Postharvest Biol Technol. 2020; 159: 111038. https://doi.org/10.1016/j.postharvbio.2019.111038
• [13] Komaki N, Watanabe T, Ogasawara A, Sato N, Mikami T, Matsumoto T. Antifungal mechanism of hinokitiol against Candida albicans. Biol Pharm Bull. 2008; 31(4): 735-737. https://doi.org/10.1248/bpb.31.735
• [14] Domon H, Hiyoshi T, Maekawa T, Yonezawa D, Tamura H, Kawabata S, Yanagihara K, Kimura O, Kunitomo E, Terao Y. Antibacterial activity of hinokitiol against both antibiotic‐resistant and‐susceptible pathogenic bacteria that predominate in the oral cavity and upper airways. Microbiol Immunol. 2019; 63(6): 213-222. https://doi.org/10.1111/1348-0421.12688
• [15] Suvarna V, Bore B, Bhawar C, Mallya R. Complexation of phytochemicals with cyclodextrins and their derivatives an update. Biomed Pharmacother. 2022; 149: 112862. https://doi.org/10.1016/j.biopha.2022.112862
• [16] Ye J, Xu YF, Lou LX, Jin K, Miao Q, Ye X, Xi Y. Anti-inflammatory effects of hinokitiol on human corneal epithelial cells: an in vitro study. Eye. 2015; 29(7): 964-971. https://doi.org/10.1038/eye.2015.62
• [17] Lee JH, Moon JH, Lee YJ, Park SY. SIRT1, a class III histone deacetylase, regulates LPS-induced inflammation in human keratinocytes and mediates the anti-inflammatory effects of hinokitiol. J Invest Dermatol. 2017; 137(6): 1257 12666. https://doi.org/10.1016/j.jid.2016.11.044
• [18] Varier KM, Sumathi T. Hinokitiol offers neuroprotection against 6-OHDA-induced toxicity in SH-SY5Y neuroblastoma cells by downregulating mRNA expression of MAO/α-Synuclein/LRRK2/PARK7/PINK1/PTEN genes. Neurotox Res. 2019; 35(4): 945-954. https://doi.org/10.1007/s12640-018-9988-x
• [19] Lu WJ, Lin KH, Tseng MF, Yuan KC, Huang HC, Sheu JR, Chen RJ. New therapeutic strategy of hinokitiol in haemorrhagic shock‐induced liver injury. J Cell Mol Med. 2019; 23(3): 1723-1734. https://doi.org/10.1111/jcmm.14070
• [20] Gao M, Zou Z, Qiu Y, Sumayyah G, Jiang X, Su J, Duan X, Chen C, Qiu J. Preventive effects of traditional Chinese medicine formula Huoxiangzhengqi against lipopolysaccharide-induced inflammatory response. Phytomedicine. 2022; 99: 153968. https://doi.org/10.1016/j.phymed.2022.153968
• [21] Dong N, Li X, Xue C, Zhang L, Wang C, Xu X, Shan A. Astragalus polysaccharides alleviates LPS‐induced inflammation via the NF‐κB/MAPK signaling pathway. J Cell Physiol. 2020; 235(7-8): 5525-5540. https://doi.org/10.1002/jcp.29452
• [22] Qi L, Wang M, He J, Jia B, Ren J, Zheng S. E3 ubiquitin ligase ITCH improves LPS-induced chondrocyte injury by mediating JAG1 ubiquitination in osteoarthritis. Chem Biol Interact. 2022; 360: 109921. https://doi.org/10.1016/j.cbi.2022.109921
• [23] Liu H, Yu X, Yu S, Kou J. Molecular mechanisms in lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Int Immunopharmacol. 2015; 29(2): 937-946. https://doi.org/10.1016/j.intimp.2015.10.010
• [24] Yang X, Zhang F, Du Y, Cui W, Dou Y, Lin Y, Zhao Z, Ma X. Effect of tetrahedral DNA nanostructures on LPS induced neuroinflammation in mice. Chin Chem Lett. 2022;33(4): 1901-1906. https://doi.org/10.1016/j.cclet.2021.10.029
• [25] Wu Y, Zhang Y, Wang L, Diao Z, Liu W. The role of autophagy in kidney inflammatory injury via the NF-κBroute induced by LPS. Int J Med Sci. 2015; 12(8): 655-666. https://doi.org/10.7150/ijms.12460.
• [26] Ozmen O, Topsakal S. Pregabalin ameliorates lipopolysaccharide-induced pancreatic inflammation in aged rats. Endocr Metab Immune Disord Drug Targets. 2019; 19(8): 1141-1147. https://doi.org/10.2174/1871530319666190306095532.
• [27] Guo W, Mao B, Tang X, Zhang Q, Zhao J, Cui S, Zhang H. Lactobacillus paracasei CCFM1223 protects against lipopolysaccharide-induced acute liver injury in mice by regulating the “gut–liver” axis. Microorganisms. 2022; 10(7): 1321. https://doi.org/10.3390/microorganisms10071321
• [28] Li D, Wang M, Ye J, Zhang J, Xu Y, Wang Z, Zhao M, Ye D, Wan J. Maresin 1 alleviates the inflammatory response, reduces oxidative stress and protects against cardiac injury in LPS-induced mice. Life Sci. 2021; 277: 119467. https://doi.org/10.1016/j.lfs.2021.119467
• [29] Lai JL, Liu YH, Liu C, Qi MP, Liu RN, Zhu XF, Zhou QG. Indirubin inhibits LPS-induced inflammation via TLR4 abrogation mediated by the NF-kB and MAPK signaling pathways. Inflamm. 2017; 40(1): 1-12. https://doi.org/10.1007/s10753-016-0447-7
• [30] Zhang J, Ma Y, Li W. Curcumin reduces inflammation in mice with the psoriasis model by inhibiting NLRP3 inflammatory bodies. Cell Mol Biol. 2021; 67(6): 48-54. https://doi.org/10.14715/cmb/2021.67.6.7
• [31] Leiguarda C, Potilinski C, Rubione J, Tate P, Villar MJ, Montaner A, Bisagno V, Constandil L, Brumovsky PR. IMT504 Provides analgesia by modulating cell infiltrate and inflammatory milieu in a chronic pain model. J Neuroimmune Pharmacol. 2021; 16(3): 651-666. https://doi.org/10.1007/s11481-020-09971-2
• [32] Chen ZF. A neuropeptide code for itch. Nat Rev Neurosci. 2021; 22(12): 758-776. https://doi.org/10.1038/s41583 021-00526-9
• [33] Olaseinde OF, Owoyele BV. Chondroitin and glucosamine sulphate reduced proinflammatory molecules in the DRG and improved axonal function of injured sciatic nerve of rats. Sci Rep. 2022; 2(1): 3196. https://doi.org/10.1038/s41598-022-06554-4
• [34] Cagli A, Senol SP, Temiz‐Resitoglu M, Guden DS, Sari AN, Sahan‐Firat S, Tunctan B. Soluble epoxide hydrolaseinhibitor trifluoromethox-yphenyl‐3‐(1‐propionyl-piperidin‐4‐yl) urea prevents hyperalgesia through regulating NLRC4 inflammasome‐related pro‐inflammatory and anti‐inflammatory signaling pathways in the lipopolysaccharide‐induced pain mouse model. Drug Dev Res 2021; 82(6): 815-825. https://doi.org/10.1002/ddr.21786
• [35] Halder D, Das S, Joseph A, Jeyaprakash RS. Molecular docking and dynamics approach to in silico drug repurposing for inflammatory bowels disease by targeting TNF alpha. J Biomol Struct Dyn. 2023;41(8):3462-3475. https://doi.org/10.1080/07391102.2022.2050948
• [36] Kaneko N, Kurata M, Yamamoto T, Morikawa S, Masumoto J. The role of interleukin-1 in general pathology. Inflamm Regen. 2019;39:12. https://doi.org/10.1186/s41232-019-0101-5
• [37] Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014; 6(10): 16295-16305. https://doi.org/10.1007/s10753-022-01631-2
• [38] Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y. Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors. Biochim Biophys Acta. 2015; 1851(4): 414-421. https://doi.org/10.1016/j.bbalip.2014.07.008
• [39] Yu T, Wang P, Wu Y, Zhong J, Chen Q, Wang D, Chen H, Hu S, Wu Q. MiR-26a reduces ınflammatory responses via ınhibition of PGE2 production by targeting COX-2. Inflammation. 2022; 45(4): 1484-1495. doi: 10.1007/s10753 022-01631-2
• [40] Hashemzaei M, Rezaee R. A review on pain‐relieving activity of berberine. Phytother Res. 2021; 35(6): 2846-2853. https://doi.org/10.1002/ptr.6984
• [41] Poulaki S, Rassouli O, Liapakis G, Gravanis A, Venihaki M. Analgesic and Anti-Inflammatory Effects of the Synthetic Neurosteroid Analogue BNN27 during CFA-Induced Hyperalgesia. Biomedicines. 2021;9(9):1185. https://doi.org/10.3390/biomedicines9091185
• [42] Anderson KV. Toll signaling pathways in the innate immune response. Curr Opin Immunol. 2000;12(1):13-19. https://doi.org/10.1016/s0952-7915(99)00045-x.
• [43] Rosadini CV, Kagan JC. Early innate immune responses to bacterial LPS. Curr Opin Immunol. 2017; 44: 14-19. https://doi.org/10.1016/j.coi.2016.10.005
• [44] Lewis SM, Williams A, Eisenbarth SC. Structure and function of the immune system in the spleen. Sci Immunol. 2019; 4(33): 6085-6092. https://doi.org/10.1126/sciimmunol.aau6085
• [45] Ema M, Harazono A, Fujii S, Kawashima K. Evaluation of developmental toxicity of β-thujaplicin (hinokitiol) following oral administration during organogenesis in rats. Food Chem Toxicol. 2004; 42(3): 465-470. https://doi.org/10.1016/j.fct.2003.10.009
• [46] Imai N, Doi Y, Nabae K, Tamano S, Hagiwara A, Kawabe M, Ichihara T, Ogawa, K, Shirai T. Lack of hinokitiol (beta-thujaplicin) carcinogenicity in F344/DuCrj rats. J Toxicol Sci. 2006;31(4):357-370. https://doi.org/10.2131/jts.31.357
• [47] Jayakumar T, Liu CH, Wu GY, Lee TY, Manubolu M, Hsieh CY. Hinokitiol inhibits migration of A549 lung cancer cells via suppression of MMPs and induction of antioxidant enzymes and apoptosis. Int J Mol Sci. 2018; 19(4): 939 947. https://doi.org/10.3390/ijms19040939
• [48] Gunjegaonkar SM, Shanmugarajan TS. Methyl jasmonate a stress phytohormone attenuates LPS induced in vivo and in vitro arthritis. Mol Biol Rep. 2019; 46(1): 647-456. https://doi.org/10.1007/s11033-018-4520-1
• [49] Wijekoon HS, Kim S, Bwalya EC, Fang J, Aoshima K, Hosoya K, Okumura M. Anti-arthritic effect of pentosan polysulfate in rats with collagen-induced arthritis. Res Vet Sci. 2019; 122: 179-185. https://doi.org/10.1016/j.rvsc.2018.11.028
• [50] Gunjegaonkar SM, Wankhede SB, Shanmugarajan TS, Shinde SD. Bioactive role of plant stress hormone methyl jasmonate against lipopolysaccharide induced arthritis. Heliyon. 2020; 6(11): 5432-5445. https://doi.org/10.1016/j.heliyon.2020.e05432
• [51] Sehgal R, Kumar VL. Calotropisprocera latex-induced inflammatory hyperalgesia-effect of anti-inflammatory drugs. Mediators Inflamm. 2005; 31(4): 216-220. https://doi.org/10.1111/j.1474-8673.2007.00405.x
• [52] Li X, Jiang C, Zhu W. Crocin reduces the inflammation response in rheumatoid arthritis. Biosci Biotechnol Biochem. 2017; 81(5): 891-898. https://doi.org/10.1080/09168451.2016.1263145
• [53] Li P, Feng M, Hu X, Zhang C, Zhu J, Xu G, Li L, Zhao Y. Biological evaluation of acellular bovine bone matrix treated with NaOH. J Mater Sci Mater Med. 2022; 33(7): 58. https://doi.org/10.1007/s10856-022-06678-z